Yes, there are growing concerns about resistance to artemisinin and its derivatives, including DHA. Resistance is primarily reported in the Greater Mekong Subregion. This resistance can lead to delayed parasite clearance and treatment failures. Continuous [epidemiological surveillance]() and research are crucial to monitor resistance patterns and develop strategies to mitigate its impact.
